About six months after coming out of stealth with $50 million in funding, Latent Labs has released a web-based AI model for ...

Generative AI will continue to be a driving force in innovation, but its future must be sustainable by design.

The Food and Drug Administration has granted permission for Juul to continue selling its e-cigarettes, offering some reprieve ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Pennsylvanians will benefit from $100 billion in energy- and artificial intelligence-related investments to energize the nation's growing AI economy.

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

Wayve was among the first unicorn AI startups in the UK, getting funding of over $1 billion for its self-driving artificial ...

Goldman Sachs initiates buy rating on Nvidia with $185 price target following the company's historic $4 trillion market ...